Table 1 Baseline characteristics of the study population
Variable | Survivors (n = 663) | Non-survivors (n = 183) | P-value |
|---|---|---|---|
Age (year) | 62 ± 12 | 67 ± 12 | < 0.001 |
Female n (%) | 158 (24) | 59 (32) | 0.021 |
History of HF n (%) | 11 (2) | 15 (8) | < 0.001 |
Hypertension n (%) | 301 (45) | 107 (59) | 0.002 |
Diabetes mellitus n (%) | 117 (27) | 77 (42) | < 0.001 |
Hyperlipidemia n (%) | 94 (14) | 31 (17) | 0.351 |
Current smoking n (%) | 210 (32) | 41 (22) | 0.015 |
Previous CAD n (%) | 183 (28) | 66 (26) | 0.026 |
Prior stroke/TIA n (%) | 21 (3) | 19 (10) | < 0.001 |
Type of ACS n (%) | |||
STEMI | 419 (63) | 105 (57) | 0.151 |
NSTEMI | 179 (27) | 62 (34) | 0.102 |
UA | 56 (8) | 13 (7) | 0.557 |
Major bleeding n (%) | 14 (2) | 9 (5) | 0.039 |
Killip class ≥2 n (%) | 33 (5) | 48 (26) | < 0.001 |
Medication at discharge | |||
Beta-blocker n (%) | 580 (88) | 136 (74) | < 0.001 |
Statin n (%) | 539 (81) | 143 (78) | 0.339 |
ACE-I/ARB n (%) | 555 (84) | 126 (99) | < 0.001 |
Outcomes | |||
In-hospital death n (%) | 0 (0) | 30 (16) | < 0.001 |
Stroke n (%) | 14 (2) | 9 (5) | 0.039 |
HF admission n (%) | 24 (4) | 25 (14) | < 0.001 |
Myocardial reinfarction n (%) | 62 (9) | 17 (9) | 0.980 |
TVR n (%) | 78 (12) | 11 (6) | 0.025 |
Cardiac death n (%) | 0 (0) | 59 (32) | < 0.001 |